What 26 Analyst Ratings Have To Say About Albemarle
In the preceding three months, 26 analysts have released ratings for Albemarle (NYSE:ALB), presenting a wide array of perspectives from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 6 | 5 | 15 | 0 | 0 |
| Last 30D | 1 | 0 | 1 | 0 | 0 |
| 1M Ago | 4 | 3 | 3 | 0 | 0 |
| 2M Ago | 1 | 0 | 5 | 0 | 0 |
| 3M Ago | 0 | 2 | 6 | 0 | 0 |
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $153.96, a high estimate of $230.00, and a low estimate of $85.00. This current average reflects an increase of 35.1% from the previous average price target of $113.96.
Investigating Analyst Ratings: An Elaborate Study
An in-depth analysis of recent analyst actions unveils how financial experts perceive Albemarle. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Jeffrey Zekauskas | JP Morgan | Raises | Neutral | $195.00 | $80.00 |
| Laurence Alexander | Jefferies | Raises | Buy | $230.00 | $210.00 |
| Michael Sison | Wells Fargo | Raises | Equal-Weight | $174.00 | $135.00 |
| Patrick Cunningham | Citigroup | Raises | Neutral | $180.00 | $150.00 |
| Colin Rusch | Oppenheimer | Raises | Outperform | $207.00 | $109.00 |
| Peter Osterland | Truist Securities | Raises | Buy | $205.00 | $125.00 |
| Corinne Blanchard | Deutsche Bank | Raises | Buy | $185.00 | $125.00 |
| Joshua Spector | UBS | Raises | Buy | $205.00 | $185.00 |
| John Roberts | Mizuho | Raises | Neutral | $156.00 | $132.00 |
| Ben Isaacson | Scotiabank | Raises | Sector Outperform | $200.00 | $85.00 |
| Ben Kallo | Baird | Raises | Outperform | $210.00 | $113.00 |
| Laurence Alexander | Jefferies | Raises | Buy | $167.00 | $152.00 |
| Michael Sison | Wells Fargo | Raises | Equal-Weight | $135.00 | $100.00 |
| Patrick Cunningham | Citigroup | Raises | Neutral | $150.00 | $100.00 |
| John Roberts | Mizuho | Raises | Neutral | $132.00 | $110.00 |
| Joshua Spector | UBS | Raises | Buy | $185.00 | $107.00 |
| Corinne Blanchard | Deutsche Bank | Raises | Hold | $125.00 | $110.00 |
| Ben Kallo | Baird | Raises | Neutral | $113.00 | $81.00 |
| Joel Jackson | BMO Capital | Raises | Outperform | $136.00 | $125.00 |
| Joshua Spector | UBS | Raises | Neutral | $107.00 | $85.00 |
| John Roberts | Mizuho | Raises | Neutral | $110.00 | $92.00 |
| Michael Sison | Wells Fargo | Raises | Equal-Weight | $100.00 | $90.00 |
| Stephen Richardson | Evercore ISI Group | Raises | In-Line | $100.00 | $88.00 |
| Arun Viswanathan | RBC Capital | Raises | Outperform | $120.00 | $117.00 |
| Ben Isaacson | Scotiabank | Raises | Sector Perform | $85.00 | $70.00 |
| Peter Osterland | Truist Securities | Raises | Hold | $91.00 | $87.00 |
Key Insights:
- Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Albemarle. This insight gives a snapshot of analysts' perspectives on the current state of the company.
- Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Albemarle compared to the broader market.
- Price Targets: Understanding forecasts, analysts offer estimates for Albemarle's future value. Examining the current and prior targets provides insight into analysts' changing expectations.
Capture valuable insights into Albemarle's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
Stay up to date on Albemarle analyst ratings.
Discovering Albemarle: A Closer Look
Albemarle is one of the world's largest lithium producers. In the lithium industry, the majority of demand comes from batteries, where lithium is used as the energy storage material, particularly in electric vehicles. Albemarle is a fully integrated lithium producer. Its upstream resources include salt brine deposits in Chile and the US and two hard rock mines in Australia, both of which are joint ventures. The company operates lithium refining plants in Chile, the US, Australia, and China. Albemarle is a global leader in the production of bromine, used in flame retardants.
A Deep Dive into Albemarle's Financials
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
Decline in Revenue: Over the 3M period, Albemarle faced challenges, resulting in a decline of approximately -3.46% in revenue growth as of 30 September, 2025. This signifies a reduction in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Materials sector.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of -15.47%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of -2.57%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): Albemarle's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of -1.18%, the company may face hurdles in achieving optimal financial performance.
Debt Management: Albemarle's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.48.
The Core of Analyst Ratings: What Every Investor Should Know
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Latest Ratings for ALB
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Feb 2022 | RBC Capital | Maintains | Outperform | |
| Feb 2022 | Mizuho | Maintains | Neutral | |
| Feb 2022 | Keybanc | Maintains | Underweight |
Posted-In: BZI-AARAnalyst Ratings
